Biolyz

Biolyz is an Austria‑based biotech startup devoted to transforming how we monitor physiology by using saliva rather than blood. Their system uses a simple 60‑second swab, mass‑spectrometry analytics and AI‑driven dashboards to deliver more than 125 biomarkers—covering hormones (e.g., cortisol, testosterone), inflammation and metabolic markers—within 24–48 hours.

Where many diagnostics remain invasive, episodic or expensive, Biolyz aims to provide high‑frequency, high‑resolution data in a painless and scalable manner. Their manifesto positions this as a shift from reactive health‑care to continuous biological intelligence—especially relevant for elite teams, biohackers and longevity seekers.

By making biomarker trends visible, Biolyz helps users identify early signs of fatigue, elevated injury risk, metabolic strain or recovery deficits—and act before decline occurs. For a longevity‑oriented individual, the ability to monitor underlying physiology (instead of only relying on how you feel) supports optimized training, accelerated recovery, reduced wear and tear and ultimately improved healthspan.